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PRELIMINARY AND SHORT REPORTS
TAILURE OF ADENOSINE-5-MONOPHOSPHATE TO AFFECT FAVORABLY
PRURITUS OF ATOPIC DERMATITIS*
ADOLPH ROSTENBERG, JR., M.D., MATTHEW J. BRUNNER, M.D. AND
J. MURRAY RIDDELL, Ja., M.D.
Recently, Rottino (1, 2) has reported the use of adenosine-5-monophosphate in the
treatment of forty-four patients with pruritus from a variety of causes. His results were
as follows: in 14 complete subsidence, in 15 marked improvement, in 5moderate improve-
ment, in 2 mild improvement, and no benefit in 8.
Because of the fact that itching is an essential feature of atopic dermatitis, and may
well be the cardinal factor in the production of the lesions, it was thought worthwhile to
try the effect of adenosine-5-monophosphate' in cases of this disease.
PROCEDURE
Eight patients with atopic dermatitis2 were admitted to the hospital for a trial of the
product. The patients were all adults with moderately severe to severe cases of atopic
dermatitis. All of the patients complained of itching and difficulty of sleeping because of
this. As evidence for their pruritus practically all of the patients had obvious excoriations.
It was deemed necessary to hospitalize the patients; firstly, because it is recommended
that the drug be given at hourly intervals, which would have been difficult in the case of
ambulatory patients; secondly, to control any environmental factors which might affect
their pruritus; and thirdly, to have a better opportunity to observe the patients in order
to estimate any objective changes that might result. The dosage schedule was that suggested
by both Rottino and the manufacturer; namely, 20 mgm. hourly for five consecutive hours
over a period of three days. The drug was given intramuscularly. It was felt, however, that
the mere effect of hospitalizing these patients and the ritual of the many daily injections
might have a salutary effect on the itching. Consequently, to control this possibility, we
observed the patients for a day or two after hospitalization during which time no medica-
tion was given. For the next three days the patients were given saline injections exactly
in accordance with the schedule that was to be used when the adenosine-5-monophosphate
was started. After the completion of the saline series, a day or two of rest was given, and
then the adenosine was started.
RESULTS
One patient claimed she experienced marked relief of her pruritus from the first series
of injections (saline) but had no relief from the second series (MY-B-DEN). One patient
thought she had received much relief of her pruritus from the second series of injections
(MY-B-DEN), whereas, the first series (saline) had not helped her. One patient thought
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1 Supplies of the drug were furnished us by the Ernst Bischoff Co., Inc. The drug is mar-
keted by them under the name, MY-B-DEN, in 1 cc. ampules containing in aqueous solu-
tion 20 mg./cc. of the crystalline-free acid as a sodium salt.
2 In addition, a case of erythema multiforme bullosum or pemphigus, with marked
pruritus, was treated with the drug. She received five hourly intramuscular injections for
three consecutive days. No benefit was noted.
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she received relief starting with the first series and continuing through the second series.
The remainder (5) experienced no relief of their pruritusth eithr wie series.
CONCLUSION
Adenosine-5-monophosphate was not found to be of any value for the relief of pruritus
in the cases of atopic dermatitis treated.
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